D. Brock

M. Heikinheimo, D. Brock, M. Seppälä, 1980, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Linkage analysis of maturity-onset diabetes of the young (MODY): genetic heterogeneity and nonpenetrance.

S. Antonarakis, D. Bowden, G. Akots, 1992, American journal of human genetics.

Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region.

J. Connor, R. Arngrímsson, F. Soubrier, 1997, American journal of human genetics.

SmaI and HhaI polymorphisms in the 5' region of the human von Willebrand factor gene (F8VWF).

D. Bonthron, D. Brock, L. Strain, 1991, Nucleic acids research.

Impact of maternal serum alpha-fetoprotein screening on antenatal diagnosis

D. Brock, 1982, British medical journal.

Changes in maternal age distribution and their possible impact on demand for prenatal diagnostic services

D. Brock, S. Holloway, 1988, British medical journal.

Fertility of older women

D. Brock, S. Holloway, 1990, The Lancet.

Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.

D. Brock, W. Liston, M. Mennie, 1992, Journal of medical genetics.

Triacetate and Fumarylacetoacetate

D. Williamson, D. Brock, 1974 .

β-Hydroxydecanoyl Thioester Dehydrase I. PURIFICATION AND PROPERTIES

K. Bloch, L. Kass, D. Brock, 1967 .

Purification of a diketo acid hydrolase from rat liver and its use for the enzymic determination of 3,5-dioxohexanoate (triacetate).

D. Williamson, D. Brock, 1968, The Biochemical journal.

Control of the synthesis of long-chain fatty acids and triacetic acid in E. coli.

K. Bloch, D. Brock, 1966, Biochemical and biophysical research communications.

Heterozygote Screening for Cystic Fibrosis

D. Brock, D. Brock, 1994, European journal of human genetics : EJHG.

Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis

C. Hayward, S. Colville, R. Swingler, 1999, Neurology.

Pancreatic lipase and phospholipase A2 concentration in amniotic fluid and the prenatal diagnosis of cystic fibrosis

D. Brock, J. Eskola, D. Gebhardt, 1985, British journal of obstetrics and gynaecology.

Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.

M. Corey, L. Tsui, T. Dörk, 1992, American journal of human genetics.

Predictive testing for Huntington disease: social characteristics and knowledge of applicants, attitudes to the test procedure and decisions made after testing

A. Wright, D. Brock, L. Barron, 1994, Clinical genetics.

Homozygosity for Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis.

C. Hayward, R. Swingler, R. Minns, 1998, Journal of medical genetics.

The use of commercial antisera in resolving the cholinesterase bands of human amniotic fluids.

D. Brock, P. Bader, 1983, Clinica chimica acta; international journal of clinical chemistry.

Cystic fibrosis mutation analysis: Report from 22 U.K. regional genetics laboratories

M. Tassabehji, D. Barton, G. Taylor, 1995, Human mutation.

Beta-hydroxydecanoyl thioester dehydrase. I. Purification and properties.

K. Bloch, L. Kass, D. Brock, 1967, The Journal of biological chemistry.

Presymptomatic testing for Huntington's disease

A. Curtis, D. Brock, J. Raeburn, 2004, Human Genetics.

Foeto-Specific Proteins in Prenatal Diagnosis

D. Brock, 1979 .

First‐trimester prenatal diagnosis of hypophosphatasia: Experience with 16 cases

D. Brock, L. Barron, 1991, Prenatal diagnosis.

Transamination and deamination of halogenated aromatic amino acids.

R. P. Spencer, D. Brock, 1962, Endocrinology.

Confirmation of prenatal diagnosis of cystic fibrosis by DNA typing of fetal tissues.

A. Curtis, D. Brock, L. Strain, 1988, Journal of medical genetics.

Workshop on the Prenatal Diagnosis of Cystic Fibrosis

D. Brock, 1987 .

DNA probes or microvillar enzymes or both for prenatal diagnosis of cystic fibrosis.

D. Brock, 1986, Journal of medical genetics.

Heterogeneity Analysis in40X-LinkedRetinitis Pigmentosa Families

M. Jay, M. Dempster, A. Carothers, 1994 .

Controlled trial of serum isoelectric focusing in the detection of the cystic fibrosis gene

C. Hayward, D. Brock, M. Super, 2004, Human Genetics.

The Principles of Human Biochemical Genetics

D. Brock, 1981 .

Letter: Predictive value of amniotic-fluid macrophages in gross C.N.S. defects.

D. Brock, M. Ruttiman, M. Nelson, 1974, Lancet.

Group-specific component phenotyping by antibody-antigen crossed electrophoresis

R. Sutcliffe, D. Brock, 1973, Biochemical Genetics.

Amniotic fluid cell morphology in early antenatal prediction of abortion and low birth weight.

C. Gosden, D. Brock, 1978, British medical journal.

The biochemical genetics of man

Nicholas Dennis, D. Brock, O. Mayo, 1978 .